Paid Clinical Trials in Maryland

Maryland has 2,888 paid clinical trials enrolling now across cities including Baltimore, Bethesda and Rockville. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Maryland include Johns Hopkins Medicine and NIH Clinical Center, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 15, 2026.

Filter results

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

2,888 clinical trials

↓ Download CSV

DETECT-RPC Universal EM Screening

for Elder Abuse

7 locations incl. Birmingham

Sponsor: The University of Texas Health Science Center, Houston

Sex: All·Age: 18+

Code: NCT05958654·Recruiting

Apply to this trial

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

for Alzheimer Disease

40 locations incl. Phoenix

Sponsor: Lighthouse Pharmaceuticals, Inc.

Sex: All·Age: 55 - 80

Code: NCT06847321·Phase 2·Recruiting

Apply to this trial

OurRelationship-S: A Digital Relationship-Strengthening Program for Couples Experiencing Substance Misuse

for Relationship Conflict

5 locations incl. Marietta

Sponsor: OurRelationship

Sex: All·Age: 18+

Code: NCT07159633·Recruiting

Apply to this trial

Behavioral Pharmacology of Orally Administered THC and D-limonene

for Subjective Drug Effects

1 location in Baltimore

Sponsor: Johns Hopkins University

Sex: All·Age: 21 - 55·Accepts healthy volunteers

Code: NCT06378957·Phase 1·Recruiting

Apply to this trial

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

for Metastatic Renal Cell Carcinoma

Drug: Cabozantinib

8 locations incl. Baltimore

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06835972·Phase 1, Phase 2·Recruiting

Apply to this trial

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

for Prostate Cancer (Adenocarcinoma)

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male·Age: 18+

Code: NCT06616597·Phase 2·Recruiting

Apply to this trial

IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

for Wound Heal

9 locations incl. Los Angeles

Sponsor: ConvaTec Inc.

Sex: All·Age: 18+

Code: NCT06616844·Recruiting

Apply to this trial

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

for Obesity and Overweight

Drug: Tirzepatide

20 locations incl. Bessemer

Sponsor: Gan and Lee Pharmaceuticals, USA

Sex: All·Age: 18 - 75

Code: NCT06737042·Phase 2·Not Yet Recruiting

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

for Developmental and Epileptic Encephalopathy

9 locations incl. Little Rock

Sponsor: Longboard Pharmaceuticals

Sex: All·Age: 2 - 66

Code: NCT06908226·Phase 3·Enrolling By Invitation

A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

for Diabetic Retinopathy

8 locations incl. Beverly Hills

Sponsor: Vantage Biosciences Ltd

Sex: All·Age: 18+

Code: NCT06770933·Phase 2·Recruiting

Apply to this trial

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

for Neurofibromatosis Type 1

14 locations incl. Birmingham

Sponsor: Healx Limited

Sex: All·Age: 12+

Code: NCT06541847·Phase 2·Recruiting

Apply to this trial

This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

for Peripheral Nerve Injury Upper Limb

18 locations incl. Orlando

Sponsor: Neuraptive Therapeutics Inc.

Sex: All·Age: 18 - 80

Code: NCT06616025·Phase 3·Recruiting

Apply to this trial

Hearing Health Equity Through Accessible Research and Solutions for Korean Americans

for Age-related Hearing Impairment

1 location in Baltimore

Sponsor: Johns Hopkins University

Sex: All·Age: 18+

Code: NCT06803394·Enrolling By Invitation

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

for Somatostatin Receptor Positive

1 location in Bethesda

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 120

Code: NCT06427798·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

for Generalized Myasthenia Gravis

Drug: Remibrutinib

24 locations incl. Phoenix

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 75

Code: NCT06744920·Phase 3·Recruiting

Apply to this trial

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

for mCRPC (Metastatic Castration-resistant Prostate Cancer)

18 locations incl. Fountain Valley

Sponsor: Pathos AI, Inc.

Sex: Male·Age: 18+

Code: NCT06785636·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

for Ovary Cancer

2 locations incl. Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Female·Age: 18+

Code: NCT06617923·Phase 2·Recruiting

Apply to this trial

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

for Aortic Stenosis

71 locations incl. Birmingham

Sponsor: Medtronic Cardiovascular

Sex: All·Age: 18 - 105

Code: NCT06777368·Recruiting

Apply to this trial

Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

for Hypereosinophilic Syndrome

Drug: Dupilumab

1 location in Bethesda

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 18 - 99

Code: NCT06477653·Phase 2·Recruiting

Apply to this trial

Investigation of Psychedelic Effects in Psychoactive Substances

for Psychedelic Effects in Healthy Volunteers

1 location in Baltimore

Sponsor: Johns Hopkins University

Sex: All·Age: 25 - 55·Accepts healthy volunteers

Code: NCT06772753·Phase 1·Recruiting

Apply to this trial

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

for Proteinuric Kidney Disease

Drug: MZE829

72 locations incl. Decatur

Sponsor: Maze Therapeutics

Sex: All·Age: 18 - 68

Code: NCT06830629·Phase 2·Recruiting

Apply to this trial

SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization

for Prostate Cancer

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All·Age: 18 - 100

Code: NCT06389097·Recruiting

Apply to this trial

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

for Glioblastoma

32 locations incl. Phoenix

Sponsor: NovoCure GmbH

Sex: All·Age: 18+

Code: NCT06556563·Phase 3·Recruiting

Apply to this trial

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

for Extensive-stage Small-cell Lung Cancer

32 locations incl. Tucson

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06712355·Phase 3·Recruiting

Apply to this trial

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

for Hereditary Angioedema (HAE)

12 locations incl. Birmingham

Sponsor: Pharvaris Netherlands B.V.

Sex: All·Age: 12+

Code: NCT06679881·Phase 3·Recruiting

Apply to this trial

Integrity Implant System Post Market Clinical Follow-Up Study

for Rotator Cuff Tears of the Shoulder

6 locations incl. Tampa

Sponsor: Anika Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06741527·Recruiting

Apply to this trial

Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD

for Opioid Use Disorder

1 location in Baltimore

Sponsor: Potomac Health Foundations

Sex: All·Age: 13 - 21

Code: NCT06774248·Recruiting

Apply to this trial

Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)

for Endometriosis

3 locations incl. Athens

Sponsor: Johns Hopkins University

Sex: Female·Age: 18 - 45·Accepts healthy volunteers

Code: NCT06847685·Recruiting

Apply to this trial

VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

for Chronic Hepatitis B

1 location in Bethesda

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All·Age: 18 - 65

Code: NCT06092333·Phase 2·Recruiting

Apply to this trial

Nemaline Myopathy Clinical Research Network (NM-CTRN)

for Nemaline Myopathy

5 locations incl. Palo Alto

Sponsor: Stanford University

Sex: All·Age: 0 - 18

Code: NCT06774703·Not Yet Recruiting

A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity

for Overweight and Obesity

1 location in Baltimore

Sponsor: Wave Life Sciences USA, Inc.

Sex: All·Age: 18 - 60·Accepts healthy volunteers

Code: NCT06842186·Phase 1, Phase 2·Recruiting

Apply to this trial

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for Breast Carcinoma

464 locations incl. Fairbanks

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+

Code: NCT06418204·Recruiting

Apply to this trial

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for Anaplastic Large Cell Lymphoma, ALK-Negative

158 locations incl. Birmingham

Sponsor: Eastern Cooperative Oncology Group

Sex: All·Age: 18 - 75

Code: NCT06724237·Phase 3·Recruiting

Apply to this trial

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

for Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a

1 location in Bethesda

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 3 - 100

Code: NCT06732414·Recruiting

Apply to this trial

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for Metastatic Head and Neck Squamous Cell Carcinoma

53 locations incl. Birmingham

Sponsor: Bicara Therapeutics

Sex: All·Age: 18+

Code: NCT06788990·Phase 2, Phase 3·Recruiting

Apply to this trial

Improving Health for Patients With Chronic Low Back Pain in Rural Communities Through Telerehabilitation

for Chronic Low-back Pain

2 locations incl. Baltimore

Sponsor: Johns Hopkins University

Sex: All·Age: 18+

Code: NCT06471920·Recruiting

Apply to this trial

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for Diffuse Large B-Cell Lymphoma

Drug: Rituximab

42 locations incl. Gilbert

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06717347·Phase 3·Recruiting

Apply to this trial

Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing

for Enchondromatosis

1 location in Bethesda

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: All·Age: 2 - 100

Code: NCT06749366·Recruiting

Apply to this trial

CAPABLE Transplant

for Quality of Life

1 location in Baltimore

Sponsor: Johns Hopkins University

Sex: All·Age: 18 - 99

Code: NCT06326905·Recruiting

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for NonSegmental Vitiligo

Drug: Ruxolitinib

80 locations incl. Birmingham

Sponsor: Incyte Corporation

Sex: All·Age: 2 - 11

Code: NCT06548360·Phase 3·Recruiting

Apply to this trial